Raymond James & Associates’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $22.7K | Sell |
|
|||||
|
2024
Q1 | $52.3K | Sell |
|
|||||
|
2023
Q4 | $55.9K | Buy |
|
|||||
|
2023
Q3 | $42.4K | Sell |
|
|||||
|
2023
Q2 | $124K | Buy |
|
|||||
|
2023
Q1 | $262K | Sell |
|
|||||
|
2022
Q4 | $342K | Buy |
|
|||||
|
2022
Q3 | $142K | Sell |
|
|||||
|
2022
Q2 | $163K | Buy |
|
|||||
|
2022
Q1 | $229K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $247K | Buy |
|
|||||
|
2021
Q2 | $211K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $700K | Buy |
|